Gainers
- CASI Pharmaceuticals CASI shares moved upwards by 19.02% to $1.11 during Friday's after-market session. Trading volume for this security closed at 2.5 million, accounting for 100.67% of its average full-day volume over the last 100 days. The company's market cap stands at $155.1 million.
- Compass Therapeutics CMPX shares moved upwards by 9.77% to $3.82. The market value of their outstanding shares is at $374.4 million.
- Clene CLNN shares rose 6.93% to $5.4. The market value of their outstanding shares is at $335.8 million.
- Redhill Biopharma RDHL shares moved upwards by 5.65% to $2.99. The market value of their outstanding shares is at $139.6 million.
- Galera Therapeutics GRTX shares rose 4.51% to $1.62. The market value of their outstanding shares is at $42.8 million.
- Stealth BioTherapeutics MITO shares moved upwards by 4.24% to $0.98. The market value of their outstanding shares is at $56.4 million.
Losers
- Unity Biotechnology UBX shares decreased by 3.85% to $2.5 during Friday's after-market session. The market value of their outstanding shares is at $144.3 million.
- Bio-Path Holdings BPTH shares declined by 3.45% to $4.2. The market value of their outstanding shares is at $30.0 million.
- Biophytis BPTS shares decreased by 3.32% to $4.96. The market value of their outstanding shares is at $62.3 million.
- Zosano Pharma ZSAN shares declined by 2.12% to $0.62. The market value of their outstanding shares is at $73.3 million.
- Kala Pharmaceuticals KALA shares declined by 2.1% to $1.87. The market value of their outstanding shares is at $122.4 million. As per the news, the Q3 earnings report came out 4 days ago.
- Athersys ATHX shares decreased by 1.99% to $0.99. The market value of their outstanding shares is at $231.7 million. As per the news, the Q3 earnings report came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in